- Home
- LNTH vs ADMA Comparison
LNTH vs ADMA Comparison
Compare LNTH & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- ADMA
- Stock Information
- Founded
- LNTH 1956
- ADMA 2004
- Country
- LNTH United States
- ADMA United States
- Employees
- LNTH N/A
- ADMA N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LNTH Health Care
- ADMA Health Care
- Exchange
- LNTH Nasdaq
- ADMA Nasdaq
- Market Cap
- LNTH 3.8B
- ADMA 4.1B
- IPO Year
- LNTH 2015
- ADMA N/A
- Fundamental
- Price
- LNTH $58.45
- ADMA $19.41
- Analyst Decision
- LNTH Buy
- ADMA Strong Buy
- Analyst Count
- LNTH 6
- ADMA 2
- Target Price
- LNTH $74.17
- ADMA $28.50
- AVG Volume (30 Days)
- LNTH 1.3M
- ADMA 4.0M
- Earning Date
- LNTH 11-06-2025
- ADMA 11-05-2025
- Dividend Yield
- LNTH N/A
- ADMA N/A
- EPS Growth
- LNTH N/A
- ADMA 205.35
- EPS
- LNTH 2.39
- ADMA 0.86
- Revenue
- LNTH $1,525,933,000.00
- ADMA $488,559,000.00
- Revenue This Year
- LNTH N/A
- ADMA $21.08
- Revenue Next Year
- LNTH $1.98
- ADMA $25.98
- P/E Ratio
- LNTH $24.55
- ADMA $22.36
- Revenue Growth
- LNTH 1.95
- ADMA 27.63
- 52 Week Low
- LNTH $47.25
- ADMA $13.50
- 52 Week High
- LNTH $111.29
- ADMA $25.67
- Technical
- Relative Strength Index (RSI)
- LNTH 61.44
- ADMA 75.07
- Support Level
- LNTH $51.84
- ADMA $15.22
- Resistance Level
- LNTH $57.35
- ADMA $16.67
- Average True Range (ATR)
- LNTH 2.31
- ADMA 0.78
- MACD
- LNTH 0.60
- ADMA 0.44
- Stochastic Oscillator
- LNTH 93.11
- ADMA 98.69
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.